Rivest S[au] - Search Results

Year	Number of Results
1958	1
1989	3
1990	2
1991	4
1992	5
1993	7
1994	3
1995	8
1996	5
1997	9
1998	6
1999	11
2000	5
2001	11
2002	9
2003	13
2004	9
2005	7
2006	8
2007	14
2008	9
2009	10
2010	3
2011	15
2012	11
2013	14
2014	6
2015	13
2016	9
2017	4
2018	8
2019	4
2020	11
2021	16
2022	13

1

Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.

Rawji KS, Mishra MK, Michaels NJ, Rivest S, Stys PK, Yong VW. Rawji KS, et al. Among authors: rivest s. Brain. 2016 Mar;139(Pt 3):653-61. doi: 10.1093/brain/awv395. Epub 2016 Jan 29. Brain. 2016. PMID: 26912633 Free PMC article. Review.

2

Microglia.

Soulet D, Rivest S. Soulet D, et al. Among authors: rivest s. Curr Biol. 2008 Jun 24;18(12):R506-8. doi: 10.1016/j.cub.2008.04.047. Curr Biol. 2008. PMID: 18579087 Free article. No abstract available.

3

Microglia Ontology and Signaling.

ElAli A, Rivest S. ElAli A, et al. Among authors: rivest s. Front Cell Dev Biol. 2016 Jun 29;4:72. doi: 10.3389/fcell.2016.00072. eCollection 2016. Front Cell Dev Biol. 2016. PMID: 27446922 Free PMC article. Review.

4

Triggering Innate Immune Receptors as New Therapies in Alzheimer's Disease and Multiple Sclerosis.

Piec PA, Pons V, Rivest S. Piec PA, et al. Among authors: rivest s. Cells. 2021 Aug 22;10(8):2164. doi: 10.3390/cells10082164. Cells. 2021. PMID: 34440933 Free PMC article. Review.

5

Targeting innate immunity to protect and cure Alzheimer's disease: opportunities and pitfalls.

Cisbani G, Rivest S. Cisbani G, et al. Among authors: rivest s. Mol Psychiatry. 2021 Oct;26(10):5504-5515. doi: 10.1038/s41380-021-01083-4. Epub 2021 Apr 14. Mol Psychiatry. 2021. PMID: 33854189 Review.

6

Microglia in Alzheimer's disease: A multifaceted relationship.

ElAli A, Rivest S. ElAli A, et al. Among authors: rivest s. Brain Behav Immun. 2016 Jul;55:138-150. doi: 10.1016/j.bbi.2015.07.021. Epub 2015 Aug 4. Brain Behav Immun. 2016. PMID: 26254232 Review.

7

Immunotherapy for neurological diseases.

Villoslada P, Moreno B, Melero I, Pablos JL, Martino G, Uccelli A, Montalban X, Avila J, Rivest S, Acarin L, Appel S, Khoury SJ, McGeer P, Ferrer I, Delgado M, Obeso J, Schwartz M. Villoslada P, et al. Among authors: rivest s. Clin Immunol. 2008 Sep;128(3):294-305. doi: 10.1016/j.clim.2008.04.003. Epub 2008 Jun 4. Clin Immunol. 2008. PMID: 18534912 Free article. Review.

8

Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases.

Anwar S, Pons V, Rivest S. Anwar S, et al. Among authors: rivest s. Cells. 2020 Jul 1;9(7):1595. doi: 10.3390/cells9071595. Cells. 2020. PMID: 32630251 Free PMC article. Review.

9

CX3CR1 in multiple sclerosis.

Rivest S. Rivest S. Oncotarget. 2015 Aug 21;6(24):19946-7. doi: 10.18632/oncotarget.4650. Oncotarget. 2015. PMID: 26119158 Free PMC article. No abstract available.

10

Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation.

Anwar S, Rivest S. Anwar S, et al. Among authors: rivest s. Expert Opin Ther Targets. 2020 Apr;24(4):331-344. doi: 10.1080/14728222.2020.1738391. Epub 2020 Mar 12. Expert Opin Ther Targets. 2020. PMID: 32129117 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results